Goodman, L.D., Cope, H., Nil, Z., Ravenscroft, T.A., Charng, W.L., Lu, S., Tien, A.C., Pfundt, R., Koolen, D.A., Haaxma, C.A., Veenstra-Knol, H.E., Wassink-Ruiter, J.S.K., Wevers, M.R., Jones, M., Walsh, L.E., Klee, V.H., Theunis, M., Legius, E., Steel, D., Barwick, K.E.S., Kurian, M.A., Mohammad, S.S., Dale, R.C., Terhal, P.A., van Binsbergen, E., Kirmse, B., Robinette, B., Cogné, B., Isidor, B., Grebe, T.A., Kulch, P., Hainline, B.E., Sapp, K., Morava, E., Klee, E.W., Macke, E.L., Trapane, P., Spencer, C., Si, Y., Begtrup, A., Moulton, M.J., Dutta, D., Kanca, O., Undiagnosed Diseases Network, , Wangler, M.F., Yamamoto, S., Bellen, H.J., Tan, Q.K. (2021). TNPO2 variants associate with human developmental delays, neurologic deficits, and dysmorphic features and alter TNPO2 activity in Drosophila.
Am. J. Hum. Genet. 108(9): 1669--1691.